| Faisal Musa, MD | |
|
4900 Mercury Dr, Suite 100, Dearborn, MI 48126-2947 | |
| (313) 271-5577 | |
| (313) 271-2965 |
| Full Name | Faisal Musa |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 18 Years |
| Location | 4900 Mercury Dr, Dearborn, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811138787 | NPI | - | NPPES |
| 012959400 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 4301108510 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital - Dearborn | Dearborn, MI | Hospital |
| Beaumont Hospital - Wayne | Wayne, MI | Hospital |
| Beaumont Hospital - Taylor | Taylor, MI | Hospital |
| Beaumont Hospital - Trenton | Trenton, MI | Hospital |
| Beaumont Hospital - Farmington Hills | Farmington hills, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Healthcare Professionals Pc | 0345413258 | 448 |
News Archive
In a recent study published in the journal Clinical Infectious Diseases, scientists from New York City, Baltimore, Seattle, and San Diego called for an immediate public health intervention to treat young injection drug users infected with the hepatitis C virus (HCV).
Measured in billionths of a meter, self-assembling nano-sized devices designed to carry drugs and imaging agents into the body are revolutionizing medicine by improving drug solubility and bio-distribution, providing a platform for combining targeting and imaging agents, and enabling membrane barriers to be crossed as well as making drug and imaging agent combination therapies possible.
Gynecologists have long been concerned at the lack of data on whether or not women with pelvic pain and or depression before hysterectomy improve in these symptoms after surgery.
A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at the Universities of Birmingham and Warwick.
Seahorse Bioscience, Inc., the leader in instruments for assessing cellular bioenergetics, recently organized a symposium on Cancer and Mitochondrial Function featuring Douglas Green, Ph.D., from St. Jude Children's Hospital; Navdeep S. Chandel, Ph.D., from Northwestern Medical School; and Nicholas C. Denko, Ph.D., from Stanford University School of Medicine.
› Verified 3 days ago
| Entity Name | Oakwood Ambulatory Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003829441 PECOS PAC ID: 1850282914 Enrollment ID: O20040320000401 |
News Archive
In a recent study published in the journal Clinical Infectious Diseases, scientists from New York City, Baltimore, Seattle, and San Diego called for an immediate public health intervention to treat young injection drug users infected with the hepatitis C virus (HCV).
Measured in billionths of a meter, self-assembling nano-sized devices designed to carry drugs and imaging agents into the body are revolutionizing medicine by improving drug solubility and bio-distribution, providing a platform for combining targeting and imaging agents, and enabling membrane barriers to be crossed as well as making drug and imaging agent combination therapies possible.
Gynecologists have long been concerned at the lack of data on whether or not women with pelvic pain and or depression before hysterectomy improve in these symptoms after surgery.
A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at the Universities of Birmingham and Warwick.
Seahorse Bioscience, Inc., the leader in instruments for assessing cellular bioenergetics, recently organized a symposium on Cancer and Mitochondrial Function featuring Douglas Green, Ph.D., from St. Jude Children's Hospital; Navdeep S. Chandel, Ph.D., from Northwestern Medical School; and Nicholas C. Denko, Ph.D., from Stanford University School of Medicine.
› Verified 3 days ago
| Entity Name | Michigan Healthcare Professionals Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295023547 PECOS PAC ID: 0345413258 Enrollment ID: O20111109000027 |
News Archive
In a recent study published in the journal Clinical Infectious Diseases, scientists from New York City, Baltimore, Seattle, and San Diego called for an immediate public health intervention to treat young injection drug users infected with the hepatitis C virus (HCV).
Measured in billionths of a meter, self-assembling nano-sized devices designed to carry drugs and imaging agents into the body are revolutionizing medicine by improving drug solubility and bio-distribution, providing a platform for combining targeting and imaging agents, and enabling membrane barriers to be crossed as well as making drug and imaging agent combination therapies possible.
Gynecologists have long been concerned at the lack of data on whether or not women with pelvic pain and or depression before hysterectomy improve in these symptoms after surgery.
A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at the Universities of Birmingham and Warwick.
Seahorse Bioscience, Inc., the leader in instruments for assessing cellular bioenergetics, recently organized a symposium on Cancer and Mitochondrial Function featuring Douglas Green, Ph.D., from St. Jude Children's Hospital; Navdeep S. Chandel, Ph.D., from Northwestern Medical School; and Nicholas C. Denko, Ph.D., from Stanford University School of Medicine.
› Verified 3 days ago
| Entity Name | Beaumont Medical Group- Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
In a recent study published in the journal Clinical Infectious Diseases, scientists from New York City, Baltimore, Seattle, and San Diego called for an immediate public health intervention to treat young injection drug users infected with the hepatitis C virus (HCV).
Measured in billionths of a meter, self-assembling nano-sized devices designed to carry drugs and imaging agents into the body are revolutionizing medicine by improving drug solubility and bio-distribution, providing a platform for combining targeting and imaging agents, and enabling membrane barriers to be crossed as well as making drug and imaging agent combination therapies possible.
Gynecologists have long been concerned at the lack of data on whether or not women with pelvic pain and or depression before hysterectomy improve in these symptoms after surgery.
A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at the Universities of Birmingham and Warwick.
Seahorse Bioscience, Inc., the leader in instruments for assessing cellular bioenergetics, recently organized a symposium on Cancer and Mitochondrial Function featuring Douglas Green, Ph.D., from St. Jude Children's Hospital; Navdeep S. Chandel, Ph.D., from Northwestern Medical School; and Nicholas C. Denko, Ph.D., from Stanford University School of Medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Faisal Musa, MD 26901 Beaumont Blvd Ste 3d, Southfield, MI 48033-3849 Ph: () - | Faisal Musa, MD 4900 Mercury Dr, Suite 100, Dearborn, MI 48126-2947 Ph: (313) 271-5577 |
News Archive
In a recent study published in the journal Clinical Infectious Diseases, scientists from New York City, Baltimore, Seattle, and San Diego called for an immediate public health intervention to treat young injection drug users infected with the hepatitis C virus (HCV).
Measured in billionths of a meter, self-assembling nano-sized devices designed to carry drugs and imaging agents into the body are revolutionizing medicine by improving drug solubility and bio-distribution, providing a platform for combining targeting and imaging agents, and enabling membrane barriers to be crossed as well as making drug and imaging agent combination therapies possible.
Gynecologists have long been concerned at the lack of data on whether or not women with pelvic pain and or depression before hysterectomy improve in these symptoms after surgery.
A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at the Universities of Birmingham and Warwick.
Seahorse Bioscience, Inc., the leader in instruments for assessing cellular bioenergetics, recently organized a symposium on Cancer and Mitochondrial Function featuring Douglas Green, Ph.D., from St. Jude Children's Hospital; Navdeep S. Chandel, Ph.D., from Northwestern Medical School; and Nicholas C. Denko, Ph.D., from Stanford University School of Medicine.
› Verified 3 days ago
Albagir Mohamed Alarabi, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dr. Rama V Thyagarajan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd Ste 101, Medical Office Building, Dearborn, MI 48124 Phone: 313-436-2426 Fax: 313-436-2440 | |
Adeeb M Atassi, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 18181 Oakwood Blvd, Suite Number 208, Dearborn, MI 48124 Phone: 313-563-3332 | |
Mihaela A. Lupu, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Ste 208, Dearborn, MI 48124 Phone: 313-271-5670 Fax: 313-271-1053 | |
Violet Asfour, Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 18100 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-436-2578 | |
Raed Haddad, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9720 Dix, Ste B, Dearborn, MI 48120 Phone: 313-843-1973 Fax: 313-843-1961 | |
Dr. Denise Kirsch, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd Ste 101, Dearborn, MI 48124 Phone: 313-436-2426 Fax: 313-436-2440 |